Iatrogenic Cushing’s Syndrome Following Short-Term Intranasal Steroid Use

Cushing’s syndrome (CS) is common after oral steroid use and has also been reported following topical or inhaled use, but it is extremely uncommon after intranasal administration. In this paper, we present the case of a child who developed CS after intranasal application of combined moxifloxacin-dex...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Deep, KS, Shivaprasad, Ghosh, Sujoy, Mukhopadhyay, Satinath, Chowdhury, Subhankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459166/
https://www.ncbi.nlm.nih.gov/pubmed/22985615
http://dx.doi.org/10.4274/Jcrpe.726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459166/
https://www.ncbi.nlm.nih.gov/pubmed/22985615
http://dx.doi.org/10.4274/Jcrpe.726

Ejemplares similares